Question 1

What is the catalog number for DLC-A Antibody [E10K8]?

Accepted Answer

The catalog number for DLC-A Antibody [E10K8] is F3865-20uL.

Question 2

What sizes are available for DLC-A Antibody [E10K8]?

Accepted Answer

DLC-A Antibody [E10K8] is available in the following size(s): 20 µL.

Question 3

Is DLC-A Antibody [E10K8] in stock?

Accepted Answer

DLC-A Antibody [E10K8] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures DLC-A Antibody [E10K8]?

Accepted Answer

DLC-A Antibody [E10K8] is manufactured by Bimake.

Question 5

What is the estimated delivery time for DLC-A Antibody [E10K8]?

Accepted Answer

Estimated delivery time for DLC-A Antibody [E10K8] is approximately 15 business day(s), depending on your location.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 8

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

DLC-A Antibody [E10K8]

Product Specifications

Synonyms

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human FBXO32 Pre-designed siRNA Set B

Anti-Ranibizumab Non-Neutralizing Recombinant Antibody (SAA2855)

Anti-Ranibizumab Non-Neutralizing Recombinant Antibody (SAA2855)

EMP1 Antibody, Biotin conjugated

EMP1 Antibody, Biotin conjugated

A77 1726, (N- (4-Trifluoromethylphenyl) -2-cyano-3-hydroxycrotonamide, 2-Cyano-3-hydroxy-N-[4- (trifluoromethyl) phenyl]-2-butenamide) discontinued